Magnetar Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-708,272
Closed -$71.9M 1227
2025
Q4
$71.9M Buy
+708,272
New +$56.9M 0.7% 18
2025
Q3
Sell
-11,627
Closed -$620K 985
2025
Q2
$620K Buy
11,627
+4,116
+55% +$209K ﹤0.01% 518
2025
Q1
$325K Buy
+7,511
New +$380K ﹤0.01% 553
2023
Q1
Sell
-9,351
Closed -$463K 639
2022
Q4
$463K Buy
+9,351
New +$382K 0.01% 615
2022
Q3
Sell
-13,100
Closed -$516 1404
2022
Q2
$516 Buy
+13,100
New +$700K 0.01% 1141
2021
Q4
Sell
-10,358
Closed -$989K 1427
2021
Q3
$989K Buy
+10,358
New +$1.09M 0.01% 721
2020
Q2
Sell
-3,845
Closed -$223K 490
2020
Q1
$223K Buy
+3,845
New +$312K 0.01% 377
2019
Q4
Sell
-12,851
Closed -$1.16M 559
2019
Q3
$1.16M Buy
+12,851
New +$1.46M 0.03% 194

Other funds holding EXAS

Magnetar Financial's EXAS Position: Q1 2026 in Review

Magnetar Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 708,272 shares — an estimated $71.9M sold.

Magnetar Financial first reported a position in EXAS in Q3 2019 and held it in 8 quarters. The position peaked at $71.9M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Magnetar Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 708,272 Exact Sciences shares in Q1 2026, an estimated $71.9M.
  • Magnetar Financial first reported a position in Exact Sciences in Q3 2019 and held it in 8 quarters.
  • Magnetar Financial's Exact Sciences position peaked at $71.9M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.